Tim* doesn't remember the first time he took modafinil, which he says is only because he naturally has a bad memory. He guessed it was a "few years ago," when he was living in Singapore working as a ...

Adapted from a story that originally appeared on the Schizophrenia Research Forum. 2 February 2009. Modafinil, a psychostimulant prescribed mainly for narcolepsy, was first found to increase cognitive ...

Laurie Coots, a marketing executive who flies to meetings in other countries twice a week, spent years trying to conquer sleepless nights and chronic jet lag. But nothing worked, she says, and every ...

In up-all-night, work-work-work America, a prescription medication like modafinil was sure to make major inroads from the get-go. And, whether you call this novel stay-awake drug by its commercial ...

Cognition in MS Modafinil has been validated to be a "smart drug" that significantly promotes cognitive enhancement according to a new systematic review published in the journal European ...

A retrospective review of pediatric patients with spastic cerebral palsy was undertaken at Texas Tech University Health Sciences Center covering a period from January 1, 2000, until December 31, 2003.

Opinions expressed by Entrepreneur contributors are their own. Increased concentration. Unlimited energy. The ability to stay laser focused during all-night strategy sessions. Buzz on the ...

Latest research presented at the meeting of the European Association for the Study of Diabetes has associated daytime napping and drowsiness with an increased risk of Type 2 diabetes. Reuters ...

Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well Enough email with Harry Bullmore Extension of our 'natural' capacities through ...

Whether you’re a busy professional, a student facing intense academic pressure, or someone who simply wants to improve your cognition and productivity while promoting alertness, the search for ...

In patients treated with modafinil with previous assisted or unassisted ambulation, the majority (73%) showed gait improvements. When compared with the non-modafinil-treated group, only 3 (15%) showed ...